Positive 3-year results from the phase III PHOTON study were presented at the recent American Academy of Ophthalmology (AAO) ...

Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...

Edema occurs when there is swelling caused by fluid trapped in the body’s tissues. There are many types of edema, including ...

Cohort receiving 150,000 cells achieved 11-letter mean change in best corrected visual acuity (BCVA) at 6 months, ...

Hon. Olugbenga Edema, the gubernatorial candidate of the New Nigeria People’s Party (NNPP) in Ondo State, has requested the ...

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...

An Ondo State High Court sitting in Akure, the state capital, on Thursday, dismissed the suit challenging the candidacy of Mr ...

Two papers published in Journal of Orthopaedic Research Spine show the promise of PP353 through preclinical development and ...

Opuviz, which references Regeneron Pharmacueticals’ vision loss inhibitor Eylea, treats wet age-related macular degeneration, ...

In the VISION safety population, 45% of patients had serious adverse effects (AEs), the most common being pleural effusion (7 ...

The US Food and Drug Administration has approved revumenib (Revuforj — Syndax Pharmaceuticals) for relapsed or refractory ...

Kodiak's stock surged 160% since September 2023, despite initial setbacks with tarcocimab in diabetic macular edema studies.